A key conclusion of the CTTI monitoring project was that clinical trial monitoring should be viewed as one component of an overall quality framework.  Building on that effort, CTTI plans to hold a series of workshops to develop “quality-by-design” (QbD) and risk management principles that are broadly applicable to clinical trials, as well as to identify promising approaches to implement these principles.  The first workshop was held in August 2011.